Please find below the list of business opportunities related to this sector. For further information, please contact us.

•   Animal Health and Production  (315KB)

The Spanish meat industry represents more than 20% of sales of the Spanish food industry, equivalent to more than 15 billion euros per year.

•   Advanced Therapies  (315KB)

In 2009, 71 million euros for therapeutic trials using advanced therapies were allocated. It is estimated that the private sector has contributed another 50 million euros for this initiative in the same year.

•   Ageing Medicine  (330KB)

The population older than 65 years is growing rapidly, it is estimated that in the future Spain will be the country the higher proportion of older people in the world.

•   Generics and biosimilars  (319KB)

The generics market in Spain is growing annually around 15%, whereas the global pharmaceutical market grows only at 6% annual rate.

•   Bioenergy  (318KB)

Spain is currently a worldwide leader in renewable energies. Within this sector, Bioenergy offers a high-potential development and a solid attractiveness to foreign investors.

•   Biopharming  (317KB)

There are several Biopharming Research Groups in Spain. This will allow foreign companies to find key scientific and technological resources to install their operations in the country.

•   Functional food innovation  (326KB)

The Spanish food sector is boosted by EU and national initiatives that promote technology transfer, and the modernization, innovation and quality across the whole food value chain.

•   Food Quality and Biosafety  (322KB)

The food industry is one of the sectors with higher value in Spain. In 2007, the food, drinks and tobacco market reached 75 billion euros. This represents a large market, which demands food control services to maintain its quality and biosafety levels.

•   Marine Biotechnology  (321KB)

Spain, through its local companies, already started to create value from marine biotechnology. The country is open to the development of new innovative projects together with foreign investors.

•   Industrial Bioprocesses  (323KB)

Spain offers large markets, either the chemical-industrial or the energy sectors, where industrial bioprocesses can find a wide range of applications. Together, this two sectors have a market value close to 80 billion euros.

•   Oncology  (329KB)

It is estimated that the Spanish cancer market will reach close to 1.7 billion euros in annual sales in 2013.

•   Healthcare Technology  (321KB)

In Spain, large initiatives are in place for the integrated development of a new model of healthcare, including innovation in new medical devices.

•   Clinical trials  (319KB)

The high cost-benefit and quality of clinical trials in Spain is an attractive strength of the local market compared to other European countries.

•   Venture Capital  (316KB)

In the biotechnology sector, a large proportion of venture capital comes from foreign funds. This demonstrates the important inflow of foreign investment in Spain.

•   Bioinformatics  (318KB)

Big pharmaceutical companies installed in Spain will increase their demand for bioinformatics services in the short term. One driver for growth is the need of accelerating new product development and entry into the market.

•   Nanomedicine  (318KB)

Nanomedicine will evolve significantly in the next years, reaching 1 billion euros market value in 2015. In Spain, nanodrugs alone will have sales close to 100 million euros in 2012.

•   Personalized Medicine  (319KB)

Spain has wide collaboration networks between research centers, universities and hospitals that allow to establish strategies for the advancement of a translational personalized medicine unique in the global market.

Last updated: 19|01|2012